Dr Reddy's Laboratories is recalling over 3.3 lakh bottles of Cinacalcet tablets in the US due to manufacturing issues. The ...
The Economic Times on MSN2d
Dr Reddy’s recalls over 3 lakh bottles of Cinacalcet tablets in US due to manufacturing issuesAccording to the latest Enforcement Report by the US Food and Drug Administration, Dr Reddy's is recalling the 3,31,590 ...
Dr Reddy's Laboratories is recalling over 3.3 lakh bottles of Cinacalcet tablets, a medication used for treatment of high ...
The recall is due to the 'presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit', it added.
The drugmaker’s total revenue from operations in the second quarter of current fiscal rose 16.5 per cent to ₹8,016 crore.
The Statesman on MSN2d
Dr Reddy’s recalls over 3.3 lakh bottles of medication due to manufacturing issuesThe latest Enforcement Report by the US Food and Drug Administration said that Dr Reddy’s is recalling the 3,31,590 bottles ...
The U.S. unit of Indian drugmaker Dr. Reddy’s Laboratories is recalling 331,590 bottles of cinacalcet tablets used to treat hyperparathyroidism due to the presence of a known carcinogen. | The U.S.
Stocks to watch on Monday, November 4, 2024: Indian bourses are preparing for a negative start on Monday, indicated GIFT ...
Indian cement manufacturers faced declining margins in the September quarter due to lower prices and weak demand. UltraTech, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback